Recent Transactions

20-Feb-24
Pending
$1.9 billion
United States flag
Target: 

Audacy Inc.

flag not available

Advising 1L Ad Hoc Group on the pre-packaged restructuring of Audacy, one of the largest multi-platform audio content and entertainment companies with 221 radio stations in 45 distinct markets

04-Oct-23
$610 million
United States flag
Target: 

Lucky Bucks, LLC

flag not available

Advised the Term Loan Ad Hoc Group to Lucky Bucks, one of the largest Class B coin operated amusement machine (“COAM”) route operators in Georgia, on Lucky Bucks’ financial restructuring and chapter 11 process

27-Sep-23
Undisclosed
United States flag
Target: 

Slayback Pharma LLC

United States flag
Acquiror: 
Azurity Pharmaceuticals

Advised Azurity Pharmaceuticals, a pharmaceutical company specializing in the provision of innovative medicines to overlooked patients, on the acquisition of Slayback Pharma LLC ("Slayback"), a company focused on complex generic and specialty pharmaceutical products

01-Jun-23
Pending
Undisclosed
United States flag
Target: 

Interest in Joint Venture with CarepathRx Health System Solutions

United States flag
Acquiror: 
The Cigna Group

Advising Cigna on its investment in CarepathRx Health System Solutions, under Evernorth, Cigna’s health services subsidiary

10-Feb-23
Pending
$415 million
United States flag
Target: 

Gaming Services Division of Global Payments

United States flag
Acquiror: 
Parthenon Capital

Advising Parthenon Capital, a financial services & technology focused private equity firm, on its acquisition of Global Payment’s Gaming Services Division, a leading provider of on-site and digital payment processing services to companies in the gaming industry, for $415mm

23-Jan-23
Pending
$200 million
United Kingdom flag
Target: 

Clinigen Ltd’s Proleukin

United States flag
Acquiror: 
Iovance Biotherapeutics

Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Proleukin (Interleukin-2 (Aldesleukin)), to Iovance Biotherapeutics, a late-stage biotechnology company developing novel T cell-based cancer immunotherapies

30-Dec-22
$153 million
United States flag
Target: 

Annovera®, Imvexxy®, Bijuva®, and prescription prenatal vitamin products

Australia flag
Acquiror: 
Mayne Pharma

Advised TherapeuticsMD, Inc., an innovative, leading women’s healthcare company on definitive agreements to license its products to Mayne Pharma

28-Dec-22
Pending
Undisclosed
Japan flag
Target: 

Eisai Distribution Co., Ltd.

Japan flag
Acquiror: 
Yasuda Logistics Corporation

Advising Eisai, a Japanese pharmaceutical company, on the sale of Eisai Distribution, a 100% shares holding logistic subsidiary, to Yasuda Logistics Corporation, a Japanese logistic company conducting total logistic services such as Warehousing, Transportation, delivery and forwarding, and Port transportation business, etc.

23-Dec-22
Pending
Undisclosed
Germany flag
Target: 

Exyte Management GmbH

United States flag
Acquiror: 
BDT Capital Partners LLC

Advising Stumpf Capital and Georg Stumpf on the sale of a minority interest in its wholly-owned company, Exyte, a global leader in the design, engineering and delivery of high-tech facilities, to funds affiliated with BDT Capital Partners

24-Nov-22
Pending
Undisclosed
Target: 

Kyowa Kirin International’s established medicines business

Germany flag
Acquiror: 
Grünenthal

Advising Kyowa Kirin International, a subsidiary of Kyowa Kirin Co., Ltd, a Japanese global specialty pharma company, on a collaboration agreement with Grünenthal GmbH, a global, science-based, privately-owned pharmaceutical company

19-Aug-22
$2.2 billion
United States flag
Target: 

GI Alliance

United States flag
Acquiror: 
Apollo Hybrid Value Fund

Advising the management and majority physician owners of GI Alliance, the largest gastroenterology practice in the United States, on its recapitalization and buyout of minority partner, Waud Capital

05-May-22
Undisclosed
United States flag
Target: 

Airtower Networks

Acquiror: 
DIF Capital Partners

Advised Airtower Networks on its strategic growth capital raise from DIF Capital Partners

28-Mar-22
Pending
~$1.4 billion
United Kingdom flag
Target: 

Theramex

United States flag
Acquiror: 
Carlyle and PAI Partners

Advising Carlyle, the leading private equity investor, on the acquisition of Theramex, a Women’s health-focused specialty pharmaceutical company . The acquisition was jointly executed with PAI Partners

28-Mar-22
Pending
$105 million
United Kingdom flag
Target: 

Acacia Pharma Group plc

United States flag
Acquiror: 
Eagle Pharmaceuticals, Inc.

Advising Acacia, a UK-domiciled and Euronext-listed commercial stage biopharmaceutical company, on the sale to Eagle Pharmaceuticals, an integrated pharmaceutical company with R&D, manufacturing and commercial expertise

22-Feb-22
Pending
~$8.6 billion
United States flag
Target: 

TEGNA, Inc.

United States flag
Acquiror: 
Standard General

Advising TEGNA, a leading broadcasting and digital marketing services company, on its sale to Standard General, a hedge fund 

01-Feb-22
Undisclosed
United States flag
Target: 

Alteon Health

United States flag
Acquiror: 
U.S. Acute Care Solutions

Advised Alteon Health, a portfolio company of New Mountain Capital and national physician-led provider of emergency medicine, hospitalist medicine and post-acute care services, on its sale to U.S. Acute Care Solutions

28-Jan-22
Undisclosed
United States flag
Target: 

Akorn Pharmaceuticals Portfolio of Branded Ophthalmic Products

France flag
Acquiror: 
Laboratoires Théa SAS

Advised Akorn Pharmaceuticals, a specialty pharmaceuticals manufacturer and marketer, on the divestiture of its portfolio of branded ophthalmic products to Laboratoires Théa SAS

20-Jan-22
Pending
Undisclosed
United States flag
Target: 

GrowFlow Corp.

United States flag
Acquiror: 
Dama Financial

Advising Dama Financial, the nation’s largest provider of access to banking and payment solutions for the cannabis industry, on its acquisition of GrowFlow Corp, a leading business management and compliance software platform for cannabis retailers, cultivators, processors, and distributors

18-Jan-22
$321 million
United States flag
Target: 

Fusion Connect, Inc.

flag not available
Acquiror: 
N/A

Advised Fusion Connect, Inc., a leading service provider of cloud communications and secure network solutions with a focus on serving mid-market and enterprise businesses on its comprehensive balance sheet recapitalization

30-Dec-21
$100 million
United States flag
Target: 

Photonics Division of Intevac

United States flag
Acquiror: 
EOTech LLC

Advised Intevac, a leading developer of thin-film processing systems for the electronics market and high-sensitivity digital sensors for the defense industry, on the sale of its Photonics division to EOTech, a manufacturer of holographic sighting systems and accessories for military and commercial customers

07-Dec-21
$153 million
Japan flag
Target: 

Japan Medical Dynamic Marketing

Japan flag
Acquiror: 
Mitsui Chemicals

Advising Mitsui Chemicals,  one of the largest Japanese chemical companies, on the acquisition of a 30% stake in Japan Medical Dynamic Marketing, a leading orthopedic medical device manufacturer in Japan, held by NGK SPARK PLUG

01-Dec-21
Pending
Undisclosed
United States flag
Target: 

Finalsite

United States flag
Acquiror: 
Veritas Capital

Advising Bridge Growth Partners, a private equity firm focused on technology investments, on the sale of Finalsite, a leading SaaS platform serving K-12 schools and universities, to Veritas Capital

08-Nov-21
Undisclosed
United States flag
Target: 

Unison Site Management

United States flag
Acquiror: 
Ardian US LLC

Advised Ardian US LLC, on its investment in wireless infrastructure asset aggregator Unison Site Management

26-Oct-21
Undisclosed
United States flag
Target: 

Oculii Corporation

United States flag
Acquiror: 
Ambarella, Inc.

Advised Ambarella, Inc., an AI vision silicon company, on the acquisition of Oculii Corporation, a leading developer of AI software designed to enhance radar perception

29-Sep-21
~$1.1 billion
Colombia flag
Target: 

Procaps Group

United States flag
Acquiror: 
Union Acquisition Corp. II (NASDAQ: LATN)

Advised Procaps Group, a leading integrated international healthcare and pharmaceutical company, on its successful business combination with Union Acquisition Corp II (NASDAQ: LATN), a LatAm-focused special purpose acquisition company. Procaps Group now trades on the Nasdaq Global Market under the ticker symbol "PROC"

Pages

show all